DiabetOmics
Recent Finacing
Series C
Recent Raise
$5M
DiabetOmics is a US-headquartered medical diagnostics company developing a patented non-invasive saliva-based glucose monitor and early-detection assays for gestational diabetes and pre-eclampsia, pursuing regulatory approvals and India manufacturing.
Highlights
Focus Areas
Biotechnology
Diabetes
Health Care
Health Diagnostics
Medical
Recent Investors
Financials
$5M
Total Raised
1
Funding round
1
Investor